A citation-based method for searching scientific literature

Jutte van der Werff ten Bosch. Paediatr Drugs 2003
Times Cited: 6







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Susan Price, Katie Perkins, Patricia Aldridge, Jean Tretler, Joie Davis, Janet K Dale, Fred Gill, Kip R Hartman, Linda C Stork,[...]. Pediatr Blood Cancer 2009
57
83

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
66

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
66

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
149
66

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
David T Teachey, Robert Greiner, Alix Seif, Edward Attiyeh, Jack Bleesing, John Choi, Catherine Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen,[...]. Br J Haematol 2009
108
66

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Catherine S Manno, Kelly M Axsom, Timothy Andrews, John K Choi, Barbara H Greenbaum, Joseph M McMann, Kathleen E Sullivan, Susan F Travis, Stephan A Grupp. Blood 2005
103
66

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
66

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Faith Dugan, Janet K Dale, Joie Davis, Jean Tretler, John K Hurley, Thomas Fleisher, Jennifer Puck, Stephen E Straus. Br J Haematol 2005
77
66

Causes and consequences of the autoimmune lymphoproliferative syndrome.
V Koneti Rao, Stephen E Straus. Hematology 2006
45
50


Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.
Lydia Kossiva, Maria Theodoridou, Glykeria Mostrou, Effie Vrachnou, Francoise Le Deist, Frederick Rieux-Laucat, Maria G Kanariou. J Pediatr Hematol Oncol 2006
13
50

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
C E Jackson, J M Puck. Curr Opin Pediatr 1999
59
50

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
50

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
307
50

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
50

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
501
50

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
50


Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Austen Worth, Adrian J Thrasher, H Bobby Gaspar. Br J Haematol 2006
109
50

Autoimmune lymphoproliferative syndrome.
Michael C Sneller, Janet K Dale, Stephen E Straus. Curr Opin Rheumatol 2003
63
50

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
96
50

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
50

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
130
50

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
261
50

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Bénédicte Neven, Aude Magerus-Chatinet, Benoit Florkin, Delphine Gobert, Olivier Lambotte, Lien De Somer, Nina Lanzarotti, Marie-Claude Stolzenberg, Brigitte Bader-Meunier, Nathalie Aladjidi,[...]. Blood 2011
89
50

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Jutte van der Werff Ten Bosch, Peter Schotte, Alice Ferster, Nadira Azzi, Thomas Boehler, Geneviève Laurey, Mikko Arola, Christian Demanet, Rudi Beyaert, Kris Thielemans,[...]. Br J Haematol 2002
31
33


A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Jack J H Bleesing, Margaret R Brown, Cynthia Novicio, David Guarraia, Janet K Dale, Stephen E Straus, Thomas A Fleisher. Clin Immunol 2002
57
33

The Fas death factor.
S Nagata, P Golstein. Science 1995
33

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
33

Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.
K Izeradjene, L Quemeneur, M C Michallet, N Bonnefoy-Berard, J P Revillard. Transplant Proc 2001
11
33

Autoimmune lymphoproliferative syndrome (ALPS).
Jack J H Bleesing. Curr Pharm Des 2003
22
33


Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003
149
33

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Dana A Obzut, Kelly Axsom, John K Choi, Kelly C Goldsmith, Junior Hall, Jessica Hulitt, Catherine S Manno, John M Maris, Nicholas Rhodin,[...]. Blood 2006
62
33

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
33

The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
Maria Francesca Campagnoli, Letizia Garbarini, Paola Quarello, Emanuela Garelli, Adriana Carando, Valentina Baravalle, Alessandra Doria, Alessandra Biava, Annalisa Chiocchetti, Angelo Rosolen,[...]. Haematologica 2006
36
33

Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
Mihailo Dragana Janić, Cedomir Dimitrije Brasanac, Jovan Srda Janković, Bogdan Lidija Dokmanović, Radmio Nada Krstovski, Janko Nada Kraguljac Kurtović. Pediatr Blood Cancer 2009
14
33

Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Jorge A Carrasquillo, Janet K Dale, Stephen L Bacharach, Millie Whatley, Faith Dugan, Jean Tretler, Thomas Fleisher, Jennifer M Puck, Wyndham Wilson,[...]. Am J Hematol 2006
13
33

Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells.
Karin Fischer, Simon Voelkl, Jana Heymann, Grzegorz K Przybylski, Krishna Mondal, Monika Laumer, Leoni Kunz-Schughart, Christian A Schmidt, Reinhard Andreesen, Andreas Mackensen. Blood 2005
171
33

Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Pierre Bobé, Danielle Bonardelle, Karim Benihoud, Paule Opolon, Mounira K Chelbi-Alix. Blood 2006
71
33

Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology.
R S EVANS, K TAKAHASHI, R T DUANE, R PAYNE, C LIU. AMA Arch Intern Med 1951
465
33

Dominant expression of interleukin 10 but not interferon gamma in CD4(-)CD8(-)alphabetaT cells of autoimmune lymphoproliferative syndrome.
Shouichi Ohga, Akihiko Nomura, Yasushi Takahata, Kenji Ihara, Hidetoshi Takada, Hiroshi Wakiguchi, Yuji Kudo, Toshiro Hara. Br J Haematol 2002
21
33

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
33

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
117
33

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
33


Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).
Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, Kenneth Steadman, Alan T Remaley, Jeffrey I Cohen, Stephen E Straus, V Koneti Rao. Exp Hematol 2009
40
33

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio,[...]. Blood 2011
85
33

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.
Julie E Niemela, Lianghao Lu, Thomas A Fleisher, Joie Davis, Iusta Caminha, Marc Natter, Laurel A Beer, Kennichi C Dowdell, Stefania Pittaluga, Mark Raffeld,[...]. Blood 2011
87
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.